Patients’ exposure to PVC plasticizers from ECMO circuits - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue Expert Review of Medical Devices Année : 2018

Patients’ exposure to PVC plasticizers from ECMO circuits

Résumé

Background: ECMO is a therapeutic act with a high risk of exposure to diethylhexylphthalate (DEHP), plasticizer from PVC tubings. The replacement of this plasticizer with alternative compounds is recommended but the risks associated with the use of new plasticizers have not been evaluated in ECMO situations. Methods: Ex vivo ECMO models were performed with different flow rates over 6 days to evaluate the migration of plasticizers and their potential toxic risk for patient. The release of plasticizers during ECMO was measured and compared to reference value (derived no effect level, DNEL) and to cytotoxic concentration carried out with MTT test. Results: Trioctyltrimellitate (TOTM), main plasticizer present in circuit (44% w/w), is weakly released during ECMO. Concentrations are not cytotoxic and exposure doses are lower than DNEL. In contrast, DEHP doses are higher than the DNEL despite a lower presence of DEHP in the circuit (0.2%). We have shown that DEHP is not coming from the circuit but from the priming bag. Replacing this bag with a multilayer one avoids the exposure to DEHP. Conclusion: Our study shows that circuits made of PVC plasticized with TOTM against DEHP improves the safety of ECMO.
Fichier non déposé

Dates et versions

hal-01824347 , version 1 (27-06-2018)

Identifiants

Citer

Charlotte Fernandez-Canal, Pierre-Gabriel Pinta, Teuta Eljezi, Virginie Larbre, Sophie Kauffmann, et al.. Patients’ exposure to PVC plasticizers from ECMO circuits. Expert Review of Medical Devices, 2018, 15 (5), pp.377 - 383. ⟨10.1080/17434440.2018.1462698⟩. ⟨hal-01824347⟩
95 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More